Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2021 1
2023 1
2024 3
2025 2
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Cutting-edge treatments in amyotrophic lateral sclerosis: the role of molecular pathogenesis in targeted therapies.
Raoufinia R, Alyari G, Nia AT, Abbaszadegan MR, Mahmoudi A, Shafaeibajestan S, Saburi E, Tavakol-Afshari J, Hassani M, Jamali F, Salari S, Boroumand AR, Rahimi HR. Raoufinia R, et al. Among authors: boroumand ar. Stem Cell Res Ther. 2025 Nov 23;16(1):689. doi: 10.1186/s13287-025-04781-w. Stem Cell Res Ther. 2025. PMID: 41276866 Free PMC article. Review.
WITHDRAWN: Evaluation of Safety and Efficacy of Repeated Mesenchymal Stem Cell Transplantation in Patients with Amyotrophic Lateral Sclerosis (ALS) by Investigating Patient’s Specific microRNAs as Novel Biomarkers: A Clinical Trial Study.
Alkhazaali-Ali Z, Sahab-Negah S, Boroumand AR, Farkhad NK, Khodadoust MA, Ganjali R, Tavakol-Afshari J. Alkhazaali-Ali Z, et al. Among authors: boroumand ar. Curr Stem Cell Res Ther. 2025 Jan 29. doi: 10.2174/011574888X330199250106081717. Online ahead of print. Curr Stem Cell Res Ther. 2025. PMID: 39886777 Clinical Trial.
Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives.
Najafi S, Najafi P, Kaffash Farkhad N, Hosseini Torshizi G, Assaran Darban R, Boroumand AR, Sahab-Negah S, Khodadoust MA, Tavakol-Afshari J. Najafi S, et al. Among authors: boroumand ar. Iran J Basic Med Sci. 2023;26(8):872-881. doi: 10.22038/IJBMS.2023.66364.14572. Iran J Basic Med Sci. 2023. PMID: 37427325 Free PMC article. Review.
Prevalence of multiple sclerosis in north east of Iran.
Ghandehari K, Riasi HR, Nourian A, Boroumand AR. Ghandehari K, et al. Among authors: boroumand ar. Mult Scler. 2010 Dec;16(12):1525-6. doi: 10.1177/1352458510372150. Epub 2010 Jun 9. Mult Scler. 2010. PMID: 20534643 No abstract available.